Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Eledon Pharmaceuticals, Inc. ELDN

Full chart Compare
Set alert

Price alert · ELDN

All alert types
2.62 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:01 PM EST

2.62 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

2.58 Day range 2.75
1.35 52-week range 4.49
YTD
+73.51%
1 year
-39.91%

Analyst view

Price target (mean) 12.50 +377.1% upside
Target (low)
7.00
Target (mean)
12.50
Target (high)
20.50
Ratings (0m) 6 6 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6
  • 1 month ago 5
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ELDN analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.30333-0.37 – -0.16-0.29-4.6%00.0%4
Next quarter-0.28-0.28 – -0.28-0.34+17.6%00.0%1
Current year-1.34-2.77 – -0.28-1.64+18.3%00.0%5
Next year-0.93-1.12 – -0.76-1.34+30.6%00.0%3

Upgrades and downgrades

The latest rating changes

ELDN analyst upgrades and downgrades
DateFirmActionFromTo
Nov 20, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 4, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 7, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 22, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 13, 2023HC Wainwright & Co.ReiteratedBuyBuy
Oct 24, 2023HC Wainwright & Co.MaintainedBuyBuy
Sep 27, 2023Noble Capital MarketsInitiated—Outperform
Aug 22, 2023Cantor FitzgeraldReiteratedOverweightOverweight
May 26, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 1, 2022SVB LeerinkMaintained—Outperform
Nov 24, 2021HC Wainwright & Co.Maintained—Buy
Apr 27, 2021SVB LeerinkMaintained—Outperform
Mar 23, 2021Cantor FitzgeraldInitiated—Overweight
Feb 8, 2021SVB LeerinkInitiated—Outperform